Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock in August. The Food and Drug Administration (FDA) declined to approve a new drug application submitted ...

The FDA declined to approve midomafetamine (MDMA) capsules for post-traumatic stress disorder (PTSD), calling for another trial to evaluate the drug's efficacy and safety, developer Lykos Therapeutics ...

In a decision that shocked some observers, key advisers to the US Food and Drug Administration (FDA) voted that the effectiveness of the party drug MDMA for treating post-traumatic stress disorder is ...

Also known as molly or ecstasy, MDMA has the potential to treat post-traumatic stress disorder (PTSD). But psychedelic-assisted therapy can only be administered by a trained professional. Without the ...

The independent panel casted doubt on MDMA being a safe and effective treatment. A panel of independent advisers for the U.S. Food and Drug Administration voted against recommending approval of ...

An F.D.A. advisory panel dealt a setback to those seeking treatment for PTSD, citing health risks of the illegal drug and study flaws. By Andrew Jacobs The Food and Drug Administration is weighing ...

Mind Medicine (MindMed) Inc. (MNMD) is a biotech that should be on everyone's watch list. The reason why I state this is that it has been able to make substantial improvements in the MDMA treatment ...

The Defense Department is committing two $4.9 million grants to study the effects of MDMA on post-traumatic stress disorder, one of which will enroll active-duty troops as subjects. Pictured is ...

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...

MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...

An FDA advisory panel has recommended that the agency not approve the use of MDMA-assisted therapy as a treatment for PTSD. A U.S. Food and Drug Administration advisory committee voted on Tuesday ...